Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition

NCT01831661 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Fasting

Interventions

DRUG: Metformin Hydrochloride Extended-Release Tablets USP 750 mg
DRUG: GLUCOPHAGE®XR

Sponsor

IPCA Laboratories Ltd.